During the first poster session of the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

Ipsen SA is expanding its cancer portfolio with the €1 billion (US$1.16 billion) acquisition of immuno-oncology specialist ...

With the number of beats Boston Science Corp. has posted in recent years, it could be auditioning as a heavy metal drummer. Third quarter results kept up the streak, with overall sales 2% ahead of ...

Moderna Inc. stopped its efforts to develop mRNA-1647 as a vaccine for preventing congenital cytomegalovirus infection, the most common infectious cause of birth defects in the U.S. The pivotal and ...

Do men’s and women’s brains age equally? Women are more often diagnosed with Alzheimer’s disease (AD) than men. Age is the ...

Myocardial ischemia-reperfusion (MI/R) injury is a major contributor to heart failure. The long noncoding RNA (lncRNA) ...

Esophageal cancer is among the most lethal cancers with a high mortality rate worldwide. Chinese researchers have explored ...

Ventyx Biosciences Inc. rolled out positive results from the phase II study with oral, once-daily VTX-3232 in patients with ...

It has been a positive year for med tech compared to previous years, said Antoine Papiernik, chairman and managing partner at ...

Anti-inflammatory compounds can alleviate many acute and chronic diseases, including autoimmune, cardiovascular and ...

The Advanced Medical Technology Association has updated its code of ethics for interactions with health care professionals, ...

A technology that combines transcriptomic data and AI enables a novel approach to drug discovery based on the state of cells, ...